Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T15:32:41.599Z.
Calculation as of: 2026-10-06T15:32:41.599Z.
Quote observation: 2026-10-06T15:30:31.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d0cade57d6bc8828dc71ac364ddc44a4328d7c948fb2699a56d4eea8e3f6e5b7
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$1.38B
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.21B
EBITDA Yield
7.01%
TTM Avg
3.73%
3Y Avg
2.86%
5Y Avg
4.37%
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Tau Medical Ltd (DRTS) | $1.31B | N/A | N/A | N/A | N/A |
| Kardigan, Inc. (KARD)vs › | $1.27B | N/A | N/A | N/A | N/A |
| Omeros Corporation (OMER)vs › | $1.36B | N/A | N/A | N/A | N/A |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.26B | N/A | N/A | N/A | N/A |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.38B | N/A | N/A | N/A | N/A |
| Cronos Group Inc. (CRON)vs › | $1.23B | 3.56% | 5.34% | 5.34% | 5.34% |
| Omada Health (OMDA)vs › | $1.22B | 0.69% | 0.59% | 0.59% | 0.59% |
| MannKind Corporation (MNKD)vs › | $1.22B | 1.91% | 3.43% | 3.63% | 3.63% |
| Innovage Holding Corp. (INNV)vs › | $1.21B | 7.01% | 3.73% | 2.86% | 4.37% |
| The Pennant Group, Inc. (PNTG)vs › | $1.41B | 3.90% | 3.95% | 3.70% | 2.96% |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
